[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]许尧,张超,郭旭,等.肺癌不同病理类型与骨转移临床特征相关性研究[J].中华骨科杂志,2019,27(6):329-335.
XU Y,ZHANG C,GUO X,et al.The clinical feature of bone metastases in lung cancer patients with different pathological types[J].Chinese Journal of Orthpaedics,2019,27(6):329-335.
[3]COLEMAN RE.Clinical features of metastatic bone disease and risk of skeletal morbidity[J].Clin Cancer Res,2006,12(20):6243-6249.
[4]HAYDAR N,MCDONALD MM.Tumor cell dormancy-a hallmark of metastatic growth and disease recurrence in bone[J].Current Molecular Biology Reports,2018,4(2):50-58.
[5]JANNI W,VOGL FD,WIEDSWANG G,et al.Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse-a European pooled analysis[J].Clin Cancer Res,2011,17(9):2967-2976.
[6]MANSI J,MORDEN J,BLISS JM,et al.Bone marrow micrometastases in early breast cancer-30-year outcome[J].Br J Cancer,2016,114(3):243-247.
[7]BOREL M,LOLLO G,MAGNE D,et al.Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2[J].Biochimica et Biophysica Acta(BBA)-Molecular Basis of Disease,2020,1866(12):165919.
[8]OTTEWELL PD,WANG N,MEEK J,et al.Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone[J].Endocr Relat Cancer,2014,21(5):769-781.
[9]JIANG P,GAO W,MA T,et al.CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes macrophages[J].Theranostics,2019,9(10):2950-2966.
[10]OTTEWELL PD,WANG N,BROWN HK,et al.Zoledronic acid has differential antitumor activity in the pre-and postmenopausal bone microenvironment in vivo[J].Clin Cancer Res,2014,20(11):2922-2932.
[11]SCHNEIDER A,KALIKIN LM,MATTOS AC,et al.Bone turnover mediates preferential localization of prostate cancer in the skeleton[J].Endocrinology,2005,146(4):1727-1736.
[12]BYRNE NM,SUMMERS MA,MCDONALD MM.Tumor cell dormancy and reactivation in bone:Skeletal biology and therapeutic opportunities[J].JBMR Plus,2019,3(3):e10125.
[13]ZHANG M,PENG R,WANG H,et al.Nanog mediated by FAO/ACLY signaling induces cellular dormancy in colorectal cancer cells[J].Cell Death Dis,2022,13(2):159.
[14]COLEMAN RE,CROUCHER PI,PADHANI AR,et al.Bone metastases[J].Nat Rev Dis Primers,2020,6(1):83.
[15]ESPOSITO M,GUISE T,KANG Y.The biology of bone metastasis[J].Cold Spring Harb Perspect Med,2018,8(6):a031252.
[16]HE Y,LUO W,LIU Y,et al.IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer[J].J Clin Invest,2022,132(20):e157917.
[17]MIHAYLOVA MM,SHAW RJ.The AMPK signalling pathway coordinates cell growth,autophagy and metabolism[J].Nat Cell Biol,2011,13(9):1016-1023.
[18]HERZIG S,SHAW RJ.AMPK:guardian of metabolism and mitochondrial homeostasis[J].Nat Rev Mol Cell Biol,2018,19(2):121-135.
[19]INOKI K,KIM J,GUAN KL.AMPK and mTOR in cellular energy homeostasis and drug targets[J].Annu Rev Pharmacol Toxicol,2012,52(1):381-400.